Professor, Medicine, UCLA School of Medicine
Hematology
Dr. Richard J. Pietras, MD
|
|
Give Review
Richard J. Pietras, MD works in the field of Hematology. He went to David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is one of the top medical schools in the US. David Geffen School of Medicine at UCLA is ranked 13/7 in Research/PrimaryCare. Doctor Richard J. Pietras, MD has written publications. He has 45 publications published with PubMed. The lastest publication is: 'Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.'
Publications
- Antiestrogen fulvestrant enhances the antiproliferative effects of epidermal growth factor receptor inhibitors in human non-small-Cell lung cancer.
- The role of estrogen, progesterone and aromatase in human non-small-Cell lung cancer.
- Progesterone and estrogen receptor expression and activity in human non-small Cell lung cancer.
- Targeting aromatase and estrogen signaling in human non-small Cell lung cancer.
- Rational management of endocrine resistance in breast cancer: a comprehensive review of estrogen receptor biology, treatment options, and future directions.
- Aromatase expression predicts survival in women with early-stage non small Cell lung cancer.
- Membrane-associated estrogen receptor signaling pathways in human cancers.
- Estrogen receptor signaling pathways in human non-small Cell lung cancer.
- Biologic basis of sequential and combination therapies for hormone-responsive breast cancer.
- Aromatase inhibitors in human lung cancer therapy.
- Estrogen receptors and Cell signaling.
- Overview of the FASEB 2004 summer research conference on steroid hormone receptors: integration of plasma membrane and nuclear-initiated signaling in hormone action.
- Estrogen and growth factor receptor interactions in human breast and non-small Cell lung cancer Cells.
- Antiangiogenic Steroids in Human Cancer Therapy.
- Rapid nitric oxide-mediated S-nitrosylation of estrogen receptor: regulation of estrogen-dependent gene transcription.
- Interactions between estrogen and growth factor receptors in human breast cancers and the tumor-associated vasculature.
- Membrane receptors for steroid hormones: signal transduction and physiological significance.
- Thalidomide and chemotherapy combination.
- Cathepsin D in breast cancer.
- SubCellular distribution of oestrogen receptors.
- Specific internalization of estrogen and binding to nuclear matrix in isolated uterine Cells.
- Lysosomal functions in Cellular activation: propagation of the actions of hormones and other effectors.
- Cell membrane estrogen receptors resurface.
- Steroid hormone receptors in target Cell membranes.
- Estrogen-signaling pathways in lung cancer.
- Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
- Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer Cells overexpressing thi...
- Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
- The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer Cells.
- Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer Cells.
- Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer Cells.
- Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial Cells.
- Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small Cell lung cancer.
- New approaches to reverse resistance to hormonal therapy in human breast cancer.
- Targeted therapy: wave of the future.
- Biological characteristics of the pure antiestrogen fulvestrant: overcoming endocrine resistance.
- Estrogen receptors outside the nucleus in breast cancer.
- Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy.
- The combination of green tea and tamoxifen is effective against breast cancer.
- Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer.
- HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer Cells.
- Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor.
- Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer Cells with or without HER-2 gene overexpression.
- Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer.
Schools
D Geffen Sch Of MedUcla
R J amp Lucille Carver Coll Med Univ Of Ia
UCLA Med Center
Conditions Treated
- Anemia
- Sickle Cell Disease
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Education
-
UCLA Medical Center -
VA Greater Los Angeles Healthcare System -
David Geffen School of Medicine at UCLA
Hospital
-
Ronald Reagan UCLA Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Casey L. O'Connell, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Akil A. Merchant, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vasanth K. Kumar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Youram C. Nassir, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roberto Rodriguez, MD |
|
|
Dr. Richard S. Finn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James H. Breeden, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles M. Haskell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shilpa R. Shah, MD |
|
|
Dr. Hyung C. Suh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aaron E. Lisberg, MD |